Literature DB >> 29398072

Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review.

Katja Wieland1, Patrick Chhatwal1, Ralf-Peter Vonberg2.   

Abstract

BACKGROUND: Large outbreaks of infection by Acinetobacter baumannii and Pseudomonas aeruginosa have been reported. This research compares characteristics of such outbreaks.
OBJECTIVES: Determination of risk factors for the occurrence and appropriate infection control measures. DATA SOURCES: The Outbreak Database, PubMed, and reference lists of identified articles were used. Key words included nosocomial and (outbreak or epidemic) and (aeruginosa or baumannii). STUDY ELIGIBILITY CRITERIA: Articles were included if they describe distinct outbreak(s) caused by A baumannii or P aeruginosa and were published between 2000 and 2015. There were no further restrictions with respect to language or type of article.
RESULTS: One hundred fifty outbreaks by A baumannii and 131 outbreaks by P aeruginosa were included, including multidrug-resistant strains in 113 Acinetobacter and 49 Pseudomonas outbreaks. Acinetobacter outbreaks were mainly reported from intensive care units, after use of antibiotics, during mechanical ventilation, and presented with a mortality rate of 47% compared with 23% by Pseudomonas. Resistance did not alter mortality by either species. Most infection control measures were implemented or enforced more often in Acinetobacter outbreaks.
CONCLUSIONS: These findings should support staff in infection control departments and on wards if an outbreak is suspected. Better adherence to the Outbreak Reports and Intervention Studies of Nosocomial Infection guidelines in outbreak reporting is necessary. A precise definition of multidrug resistance for Acinetobacter and Pseudomonas is lacking.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Infection control; Multi drug resistance; ORION statement

Mesh:

Year:  2018        PMID: 29398072     DOI: 10.1016/j.ajic.2017.12.014

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  26 in total

Review 1.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

2.  A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.

Authors:  Marianna Meschiari; José-María Lòpez-Lozano; Vincenzo Di Pilato; Carola Gimenez-Esparza; Elena Vecchi; Erica Bacca; Gabriella Orlando; Erica Franceschini; Mario Sarti; Monica Pecorari; Antonella Grottola; Claudia Venturelli; Stefano Busani; Lucia Serio; Massimo Girardis; Gian Maria Rossolini; Inge C Gyssens; Dominique L Monnet; Cristina Mussini
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-19       Impact factor: 4.887

Review 3.  The Collaborative Cross mouse model for dissecting genetic susceptibility to infectious diseases.

Authors:  Hanifa Abu Toamih Atamni; Aysar Nashef; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2018-08-24       Impact factor: 2.957

4.  Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by Pseudomonas aeruginosa.

Authors:  Jin Zhang; Chuang Wan; Bo Yu; Chen Gao; Liqun Zhao; Xin Cheng; Feng Yang; Hao Gu; Quanming Zou; Jiang Gu; Xingyong Wang
Journal:  Hum Vaccin Immunother       Date:  2019-07-09       Impact factor: 4.526

5.  One-year molecular surveillance of carbapenem-susceptible A. baumannii on a German intensive care unit: diversity or clonality.

Authors:  Andreas F Wendel; Monika Malecki; Robin Otchwemah; Carlos J Tellez-Castillo; Samir G Sakka; Frauke Mattner
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-26       Impact factor: 4.887

6.  Efflux Pump Overexpression Profiling in Acinetobacter baumannii and Study of New 1-(1-Naphthylmethyl)-Piperazine Analogs as Potential Efflux Inhibitors.

Authors:  Morgane Choquet; Elodie Lohou; Etienne Pair; Pascal Sonnet; Catherine Mullié
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

7.  Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system.

Authors:  Michael Fruci; Keith Poole
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

8.  Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii.

Authors:  Jennifer K Singh; Felise G Adams; Melissa H Brown
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

9.  A Recombinant Snake Cathelicidin Derivative Peptide: Antibiofilm Properties and Expression in Escherichia coli.

Authors:  Mercedeh Tajbakhsh; Maziar Mohammad Akhavan; Fatemeh Fallah; Abdollah Karimi
Journal:  Biomolecules       Date:  2018-10-22

Review 10.  Spatio-Temporal Distribution of Acinetobacter baumannii in Germany-A Comprehensive Systematic Review of Studies on Resistance Development in Humans (2000-2018).

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  Microorganisms       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.